These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3919091)

  • 1. Structural and functional characterization of IL 2 receptors on activated human B cells.
    Boyd AW; Fisher DC; Fox DA; Schlossman SF; Nadler LM
    J Immunol; 1985 Apr; 134(4):2387-92. PubMed ID: 3919091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.
    Ortega G; Robb RJ; Shevach EM; Malek TR
    J Immunol; 1984 Oct; 133(4):1970-5. PubMed ID: 6206144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF; Lipsky PE
    J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    Procopio AD; Allavena P; Ortaldo JR
    J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells.
    Kehrl JH; Muraguchi A; Goldsmith PK; Fauci AS
    Cell Immunol; 1985 Nov; 96(1):38-48. PubMed ID: 2424621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
    Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
    J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
    Suzuki T; Cooper MD
    J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
    Ledbetter JA; Shu G; Gallagher M; Clark EA
    J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
    Benjamin D; Bazar LS; Wallace B; Jacobson RJ
    Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria.
    Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S
    Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.
    Zubler RH; Lowenthal JW; Erard F; Hashimoto N; Devos R; MacDonald HR
    J Exp Med; 1984 Oct; 160(4):1170-83. PubMed ID: 6434689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P
    J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.
    Chatenoud L; Dugas B; Beaurain G; Touam M; Drueke T; Vasquez A; Galanaud P; Bach JF; Delfraissy JF
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7457-61. PubMed ID: 3094009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.